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In vivo optical imaging using fluorescence and bioluminescence is superior to other methods in terms of spatiotemporal resolution and specificity, and represents a new technology for comprehensively studying living organisms in a less invasive way.
Nowadays, it is an indispensable technology for studying many aspects of cancer biology, including dynamic invasion and metastasis. In observations of fluorescence or bioluminescence signals in a living body, various problems were caused by optical characteristics such as absorption and scattering and, therefore, observation of deep tissue was difficult. Recent developments in techniques for observation of the deep tissues of living animals overcame this difficulty by improving bioluminescent proteins, fluorescent proteins, and fluorescent dyes, as well as detection technologies such as two-photon excitation microscopy. In the present review, we introduce these technological developments and in vivo application of bioluminescence and fluorescence imaging, and discuss future perspectives on the use of in vivo optical imaging technology in cancer research.
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| INTRODUCTION
In vivo imaging technology is a method for non-invasively visualizing and analyzing various biological phenomena occurring within a living body. In recent years, image diagnostic technology capable of molecular-level imaging has developed dramatically in the medical field. [1] [2] [3] In vivo imaging technology has contributed greatly to the diagnosis and treatment of various diseases, including cancer and cranial nerve diseases, and the medical system is rapidly changing as a consequence of these advances. In contrast, in basic research fields such as cell biology, it has become possible to miniaturize image diagnostic instruments used in clinical fields and apply them to studies of experimental animals. It is now possible to observe cancer cell dynamics and brain cell functions in the laboratory in living animals.
However, these instruments are still large and expensive for use in laboratories. Because PET requires a cyclotron for preparing radioactive isotope probes, facilities capable of using this technique are limited. MRI has the disadvantage of low sensitivity. In addition, because spatial resolution of PET (1-2 mm), MRI (0.025-0.1 mm) and CT (0.025-0.1 mm) is low, it remains difficult to use these devices to carry out real-time observation of specific molecules in living cells or animals in the laboratory. [1] [2] [3] Bioluminescence imaging, using the luminescent enzyme luciferase, and fluorescence imaging, using fluorescent proteins and dyes, are collectively referred to as optical imaging. These techniques have already been developed for in vitro and ex vivo applications in molecular and cellular biology. Although in vivo optical imaging has not yet been used clinically, it is attracting attention as a new research tool based on its speed, convenience, and versatility. space and we need to know whether to take functional dynamics.
Among the various imaging modalities, optical imaging is a promising method for analyzing cancer cell function and the tumor microenvironment in vivo.
| VISUALIZATION OF CANCER CELL MOVEMENTS BY IN VIVO BIOLUMINESCENCE IMAGIN G
Luciferases derived from firefly and Renilla have been widely used in reporter assays to measure the expression of target genes in cell culture. Cells that stably express luciferase protein as a result of introduction of a luciferase gene produce biopermeable luminescence after giving a substrate such as D-luciferin or coelenterazine. [8] [9] [10] With the development of ultra-sensitive charge-coupled device given, TGF-b signaling in cancer cells can be seen in the living animals. 8 We succeeded in observing TGF-b and BMP signaling in bone-metastasized breast cancer cells in living mice by bioluminescence imaging. Furthermore, protein stability can be monitored using a fusion protein in which luciferase is linked to a protein of interest. that the promoter activity of VEGF is high in the tumor microenvironment. 19 This observation suggests that the tumor promotes the production of VEGF in surrounding cells, resulting in angiogenesis.
Thus, fluorescence imaging is a promising method for visualizing and analyzing cancer cell signaling in living animals.
| VISUALIZATION OF CANCER CELL CYCLE BY IN VIVO FLUORESCENCE IMAGING
In is impossible to make sequential observations. Therefore, for studies of individual differences in tumor angiogenesis, large numbers of animals are required to achieve sufficient statistical power.
We attempted to sequentially visualize tumor angiogenesis in tumor-bearing mice in vivo, using a near-infrared fluorescence probe.
For this purpose, nude mice transplanted with HT1080 cells were treated with a near-infrared probe, AngioSense 750 (PerkinElmer, Waltham, MA, USA), which labels blood vessels, and tumor angiogenesis was observed in vivo using the OV100 and IV100 imaging systems (Olympus Corp.). 24 Tumor blood vessel analysis using an in vivo fluorescence imaging system can evaluate changes over time in the same individual, allowing highly reliable data to be obtained.
In addition, because this approach decreases the number of animals necessary for statistical analysis, it is beneficial for animal welfare, as well as being an effective tool for evaluating angiogenesis inhibitors and other drugs.
| VISUALIZATION OF E NZYME ACTIVITY BY IN VIVO FLUORESCEN CE IMAGING
Proteases play important roles during cancer invasion and metastasis. However, in in vivo imaging by conventional fluorescence macromicroscopy using near-infrared light, the signal to noise ratio of the image is low as a result of autofluorescence and high background from non-specifically bound fluorescent probe.
To overcome these problems of near-infrared fluorescence imaging, we attempted to develop a biomarker fluorescence imaging technique by two-photon excitation microscopy. 32 For this purpose, we used fluorescently labeled antibodies against cancer-specific antigens as fluorescent probes and observed cancer cells with a twophoton excitation microscope in vivo. Specifically, human cancer cells expressing CEA, a malignant marker for cancer, were s.c. transplanted into immunodeficient mice, and fluorescently labeled anti-CEA antibody was given (Figure 4 ). In the image of cancer tissue obtained on the two-photon excitation microscope, cancer cells are displayed in the same way as in a stained image of a pathological section. A method that can diagnose without resection is referred to as "optical biopsy". 33 By combining two-photon excitation microscopy and cancer-specific fluorescent probes, optical biopsy can be realized.
| CONCLUSION AND PERSPECTIVES
In vivo optical imaging is a promising technique for studying complex biology and various disease processes, including cancer, in vivo. In particular, in vivo fluorescence imaging using various fluorophores and/or fluorescent proteins, in conjunction with the appropriate type of microscopy, allows in vivo visualization of cancer cell behavior and function, as well as the tumor microenvironment. 34 Using twophoton excitation microscopy, it will be possible to diagnose cancer in vivo without biopsy (optical biopsy).
However, for the cancer fluorescence imaging technique described above, it is necessary to ensure the safety and effectiveness of the fluorescent probes that recognize cancer before they can be applied to humans. One potential solution for this problem is unstained imaging using autofluorescence, second harmonic F I G U R E 3 In vivo fluorescence imaging of mouse brain using a two-photon excitation microscope. Cerebral neocortex of a H-line transgenic mouse was imaged using a two-photon excitation microscope. Enhanced yellow fluorescent protein fluorescence was detected from layers deeper than 1 mm beneath the brain surface in an anesthetized mouse F I G U R E 4 In vivo fluorescence imaging of human cancer cells in a model mouse using a two-photon excitation microscope. Human gastric cancer MKN45 cells were inoculated into immunodeficient mice, and in vivo fluorescence imaging of the tumor mass was carried out using a two-photon excitation microscope, 24 h after injection of Alexa Fluor 594-conjugated anti-CEA antibody generation and third harmonic generation. [35] [36] [37] Further development of unstained imaging methods will provide additional insights into the applications of in vivo imaging in humans.
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